Patent · US Active

Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses

US9474747B2 · kind B2 · utility

3Cited by

4References

31Claims

0Family size

Assignee

BOEHRINGER INGELHEIM VETMEDICA GMBH · DE

Inventors

Balazs ALBRECHT · Sprendlingen, DE
Michael Aven · Mainz, DE
Janine LAMAR · Ingelheim am Rhein, DE

Key dates

Filing date	Jun 16, 2015
Grant date	Oct 25, 2016
Priority date	—
Expiry date	Jun 16, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2250/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention specifically relates to muscarinic antagonists (including long acting muscarinic antagonists (LAMAs)) for the treatment of airway disease, such as pulmonary disease, preferably recurrent airway obstruction (RAO), summer pasture associated obstructive pulmonary disease (SPAOPD), and inflammatory airway disease (IAD) in animals, preferably equines such as horses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.